Authors‘ reply to the letter to the editor by Fedai et al.: “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

Kevin C.J. Yuen; Sebastian Neggers; Thierry Brue

doi:10.1007/s11102-026-01722-5

Authors‘ reply to the letter to the editor by Fedai et al. “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

Kevin C.J. Yuen
, Sebastian Neggers
, Thierry Brue

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

Originele taal-2	Engels
Artikelnummer	118
Tijdschrift	Pituitary
Volume	29
Nummer van het tijdschrift	4
DOI's	https://doi.org/10.1007/s11102-026-01722-5
Status	Gepubliceerd - aug 2026
Extern gepubliceerd	Ja

Toegang tot document

10.1007/s11102-026-01722-5

Citeer dit

@article{936a4526b78348e699da34bc683f6a7f,

title = "Authors{\textquoteleft} reply to the letter to the editor by Fedai et al.: {\textquotedblleft}Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort{\textquotedblright}",

author = "Yuen, \{Kevin C.J.\} and Sebastian Neggers and Thierry Brue",

year = "2026",

month = aug,

doi = "10.1007/s11102-026-01722-5",

language = "English",

volume = "29",

journal = "Pituitary",

issn = "1386-341X",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Authors‘ reply to the letter to the editor by Fedai et al.

T2 - “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

AU - Yuen, Kevin C.J.

AU - Neggers, Sebastian

AU - Brue, Thierry

PY - 2026/8

Y1 - 2026/8

UR - https://www.scopus.com/pages/publications/105044163456

U2 - 10.1007/s11102-026-01722-5

DO - 10.1007/s11102-026-01722-5

M3 - Letter

AN - SCOPUS:105044163456

SN - 1386-341X

VL - 29

JO - Pituitary

JF - Pituitary

IS - 4

M1 - 118

ER -